{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:17:00Z","timestamp":1793902620487,"version":"4.8.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017531","name":"Medical and Health Research Project of Zhejiang Province","doi-asserted-by":"publisher","award":["no.2022510274"],"award-info":[{"award-number":["no.2022510274"]}],"id":[{"id":"10.13039\/501100017531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["no. 82301455"],"award-info":[{"award-number":["no. 82301455"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["no. 82373130"],"award-info":[{"award-number":["no. 82373130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhejiang Provincial Natural Science Foundation of China under Grant","award":["no. LGF22H160002"],"award-info":[{"award-number":["no. LGF22H160002"]}]},{"name":"Zhejiang Provincial Natural Science Foundation of China under Grant","award":["LMS25H160020"],"award-info":[{"award-number":["LMS25H160020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-04134-7","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T21:38:05Z","timestamp":1748468285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Intrathecal pemetrexed efficacy and cerebrospinal fluid tumor marker response in refractory leptomeningeal metastasis of non-small-cell lung cancer: a single-arm phase II trial"],"prefix":"10.1186","volume":"23","author":[{"given":"Qingsheng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luqing","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinquan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"issue":"11","key":"4134_CR1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1200\/JCO.23.02744","volume":"42","author":"IA Jaiyesimi","year":"2024","unstructured":"Jaiyesimi IA, Leighl NB, Ismaila N, Alluri K, Florez N, Gadgeel S, et al. Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. J Clin Oncol. 2024;42(11):e1\u201322.","journal-title":"J Clin Oncol"},{"issue":"suppl_4","key":"4134_CR2","doi-asserted-by":"publisher","first-page":"iv84","DOI":"10.1093\/annonc\/mdx221","volume":"28","author":"E Le Rhun","year":"2017","unstructured":"Le Rhun E, Weller M, Brandsma D, Van den Bent M, de Azambuja E, Henriksson R, et al. EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours. Ann Oncol. 2017;28(suppl_4):iv84\u201399.","journal-title":"Ann Oncol"},{"issue":"6","key":"4134_CR3","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.21037\/apm-20-2086","volume":"9","author":"Q Miao","year":"2020","unstructured":"Miao Q, Zheng X, Zhang L, Jiang K, Wu B, Lin G. Multiple combination therapy based on intrathecal pemetrexed in non-small cell lung cancer patients with refractory leptomeningeal metastasis. Ann Palliat Med. 2020;9(6):4233\u201345.","journal-title":"Ann Palliat Med"},{"issue":"10","key":"4134_CR4","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1016\/j.jtho.2021.06.034","volume":"16","author":"MM Zheng","year":"2021","unstructured":"Zheng MM, Li YS, Sun H, Chen HJ, Wu YL. Intrathecal Pemetrexed: Another Potential Treatment Modality for Tyrosine Kinase Inhibitor-Failed Leptomeningeal Metastases? J Thorac Oncol. 2021;16(10):e82\u20134.","journal-title":"J Thorac Oncol"},{"issue":"4","key":"4134_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.102384","volume":"9","author":"C Fan","year":"2024","unstructured":"Fan C, Jiang Z, Teng C, Song X, Li L, Shen W, et al. Efficacy and safety of intrathecal pemetrexed for TKI-failed leptomeningeal metastases from EGFR+ NSCLC: an expanded, single-arm, phase II clinical trial. ESMO Open. 2024;9(4): 102384.","journal-title":"ESMO Open"},{"issue":"1","key":"4134_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1158\/1078-0432.CCR-22-1585","volume":"29","author":"G Ozcan","year":"2023","unstructured":"Ozcan G, Singh M, Vredenburgh JJ. Leptomeningeal Metastasis from Non-Small Cell Lung Cancer and Current Landscape of Treatments. Clin Cancer Res. 2023;29(1):11\u201329.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"4134_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101624","volume":"8","author":"E Le Rhun","year":"2023","unstructured":"Le Rhun E, Weller M, van den Bent M, Brandsma D, Furtner J, Ruda R, et al. Leptomeningeal metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO Open. 2023;8(5): 101624.","journal-title":"ESMO Open"},{"issue":"4","key":"4134_CR8","first-page":"484","volume":"19","author":"M Chamberlain","year":"2017","unstructured":"Chamberlain M, Junck L, Brandsma D, Soffietti R, Ruda R, Raizer J, et al. Leptomeningeal metastases: a RANO proposal for response criteria. Neuro Oncol. 2017;19(4):484\u201392.","journal-title":"Neuro Oncol"},{"issue":"1","key":"4134_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jtho.2017.08.005","volume":"13","author":"SA Noonan","year":"2018","unstructured":"Noonan SA, Patil T, Gao D, King GG, Thibault JR, Lu X, et al. Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung. J Thorac Oncol. 2018;13(1):134\u20138.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"4134_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3322\/canjclin.38.2.104","volume":"38","author":"MA Virji","year":"1988","unstructured":"Virji MA, Mercer DW, Herberman RB. Tumor markers in cancer diagnosis and prognosis. CA Cancer J Clin. 1988;38(2):104\u201326.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"4134_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.6004\/jnccn.2022.0025","volume":"20","author":"DS Ettinger","year":"2022","unstructured":"Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, et al. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20(5):497\u2013530.","journal-title":"J Natl Compr Canc Netw"},{"key":"4134_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102924","volume":"58","author":"S Wang","year":"2020","unstructured":"Wang S, Tian S, Li Y, Zhan N, Guo Y, Liu Y, et al. Development and validation of a novel scoring system developed from a nomogram to identify malignant pleural effusion. EBioMedicine. 2020;58: 102924.","journal-title":"EBioMedicine"},{"issue":"8","key":"4134_CR13","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.jtho.2021.04.018","volume":"16","author":"C Fan","year":"2021","unstructured":"Fan C, Zhao Q, Li L, Shen W, Du Y, Teng C, et al. Efficacy and Safety of Intrathecal Pemetrexed Combined With Dexamethasone for Treating Tyrosine Kinase Inhibitor-Failed Leptomeningeal Metastases From EGFR-Mutant NSCLC-a Prospective, Open-Label, Single-Arm Phase 1\/2 Clinical Trial (Unique Identifier: ChiCTR1800016615). J Thorac Oncol. 2021;16(8):1359\u201368.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"4134_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347.","journal-title":"Eur J Cancer"},{"issue":"19","key":"4134_CR15","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1158\/1078-0432.CCR-23-0388","volume":"29","author":"Q Xu","year":"2023","unstructured":"Xu Q, Huang K, Meng X, Weng Y, Zhang L, Bu L, et al. Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma. Clin Cancer Res. 2023;29(19):3859\u201366.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"4134_CR16","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1097\/SLA.0000000000004432","volume":"276","author":"SWL de Geus","year":"2022","unstructured":"de Geus SWL, Hachey KJ, Nudel JD, Ng SC, McAneny DB, Davies JD, et al. Volume of Pancreas-Adjacent Operations Favorably Influences Pancreaticoduodenectomy Outcomes at Lower Volume Pancreas Centers. Ann Surg. 2022;276(2):e102\u20137.","journal-title":"Ann Surg"},{"issue":"21","key":"4134_CR17","doi-asserted-by":"publisher","first-page":"5282","DOI":"10.1158\/1078-0432.CCR-17-3717","volume":"24","author":"TA Juratli","year":"2018","unstructured":"Juratli TA, Stasik S, Zolal A, Schuster C, Richter S, Daubner D, et al. TERT Promoter Mutation Detection in Cell-Free Tumor-Derived DNA in Patients with IDH Wild-Type Glioblastomas: A Pilot Prospective Study. Clin Cancer Res. 2018;24(21):5282\u201391.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"4134_CR18","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/neuonc\/noaa298","volume":"23","author":"E Le Rhun","year":"2021","unstructured":"Le Rhun E, Devos P, Weller J, Seystahl K, Mo F, Compter A, et al. Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors. Neuro Oncol. 2021;23(7):1100\u201312.","journal-title":"Neuro Oncol"},{"issue":"2","key":"4134_CR19","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1016\/j.cllc.2022.11.011","volume":"24","author":"H Li","year":"2023","unstructured":"Li H, Zheng S, Lin Y, Yu T, Xie Y, Jiang C, et al. Safety, Pharmacokinetic and Clinical Activity of Intrathecal Chemotherapy With Pemetrexed via the Ommaya Reservoir for Leptomeningeal Metastases From Lung Adenocarcinoma: A Prospective Phase I Study. Clin Lung Cancer. 2023;24(2):e94\u2013104.","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"4134_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s12885-023-10806-5","volume":"23","author":"T Zhou","year":"2023","unstructured":"Zhou T, Zhu S, Xiong Q, Gan J, Wei J, Cai J, et al. Intrathecal chemotherapy combined with systemic therapy in patients with refractory leptomeningeal metastasis of non-small cell lung cancer: a retrospective study. BMC Cancer. 2023;23(1):333.","journal-title":"BMC Cancer"},{"issue":"5","key":"4134_CR21","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207959","volume":"102","author":"E Le Rhun","year":"2024","unstructured":"Le Rhun E, Devos P, Seystahl K, Jongen JLM, Gramatzki D, Roth P, et al. Prognostic Role of Ventricular Size and Its Dynamics in Patients With Leptomeningeal Metastasis From Solid Tumors. Neurology. 2024;102(5): e207959.","journal-title":"Neurology"},{"issue":"6","key":"4134_CR22","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3171\/2022.8.JNS221175","volume":"138","author":"KY Chen","year":"2023","unstructured":"Chen KY, Wu SG, Lai DM, Kuo LT, Huang AP. Multidisciplinary management of patients with non-small cell lung cancer with leptomeningeal metastasis in the tyrosine kinase inhibitor era. J Neurosurg. 2023;138(6):1552\u201360.","journal-title":"J Neurosurg"},{"issue":"3","key":"4134_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.annonc.2023.12.007","volume":"35","author":"MA Gouda","year":"2024","unstructured":"Gouda MA, Janku F, Wahida A, Buschhorn L, Schneeweiss A, Abdel Karim N, et al. Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST). Ann Oncol. 2024;35(3):267\u201375.","journal-title":"Ann Oncol"},{"issue":"10","key":"4134_CR24","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1038\/s41591-023-02598-9","volume":"29","author":"V Anagnostou","year":"2023","unstructured":"Anagnostou V, Ho C, Nicholas G, Juergens RA, Sacher A, Fung AS, et al. ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results. Nat Med. 2023;29(10):2559\u201369.","journal-title":"Nat Med"},{"issue":"18","key":"4134_CR25","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1056\/NEJMra1706174","volume":"379","author":"RB Corcoran","year":"2018","unstructured":"Corcoran RB, Chabner BA. Application of Cell-free DNA Analysis to Cancer Treatment. N Engl J Med. 2018;379(18):1754\u201365.","journal-title":"N Engl J Med"},{"issue":"1","key":"4134_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jmoldx.2022.10.004","volume":"25","author":"A Kramer","year":"2023","unstructured":"Kramer A, Schuuring E, Vessies DCL, van der Leest P, Geerlings MJ, Rozendal P, et al. A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice. J Mol Diagn. 2023;25(1):36\u201345.","journal-title":"J Mol Diagn"},{"key":"4134_CR27","doi-asserted-by":"publisher","first-page":"153303382210784","DOI":"10.1177\/15330338221078429","volume":"21","author":"D Geng","year":"2022","unstructured":"Geng D, Guo Q, Huang S, Zhang H, Guo S, Li X. A Retrospective Study of Intrathecal Pemetrexed Combined With Systemic Therapy for Leptomeningeal Metastasis of Lung Cancer. Technol Cancer Res Treat. 2022;21:15330338221078428.","journal-title":"Technol Cancer Res Treat"},{"issue":"5","key":"4134_CR28","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/neuonc\/noz208","volume":"22","author":"KS Nevel","year":"2020","unstructured":"Nevel KS, DiStefano N, Lin X, Skakodub A, Ogilvie SQ, Reiner AS, et al. A retrospective, quantitative assessment of disease burden in patients with leptomeningeal metastases from non-small-cell lung cancer. Neuro Oncol. 2020;22(5):675\u201383.","journal-title":"Neuro Oncol"},{"issue":"9","key":"4134_CR29","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s43018-020-0096-5","volume":"1","author":"SV Bratman","year":"2020","unstructured":"Bratman SV, Yang SYC, Iafolla MAJ, Liu Z, Hansen AR, Bedard PL, et al. Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab. Nat Cancer. 2020;1(9):873\u201381.","journal-title":"Nat Cancer"},{"issue":"7","key":"4134_CR30","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1001\/jamaoncol.2024.1779","volume":"10","author":"S Dong","year":"2024","unstructured":"Dong S, Wang Z, Zhang JT, Yan B, Zhang C, Gao X, et al. Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial. JAMA Oncol. 2024;10(7):932\u201340.","journal-title":"JAMA Oncol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04134-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04134-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04134-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T21:38:06Z","timestamp":1748468286000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04134-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4134"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04134-7","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This investigator-driven study was conceived, developed, and conducted at the First Affiliated Hospital, Zhejiang University School of Medicine. Approval was obtained from the Clinical Research Ethics Committee of the First Affiliated Hospital, School of Medicine, Zhejiang University (Reference ID: IIT20210135C-R1 and Approved No. of ethic committee: [2022C] IIT Ethics Approval No.009). Informed consents were obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was achieved from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"301"}}